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ScienceDirectParkinson’s disease (PD) is a neurological disorder affecting
dopaminergic neurons in the nigrostriatal pathways of the
brain. PD is a multifactorial disease and its causes should be
sought in detrimental interactions between genes and
environment. Since early mechanistic studies, excessive
oxidation – or oxidative stress – emerged as a recurring and
fundamental pathogenic mechanism, and consequently
received significant attention. More recent evidence obtained
at single-cell resolution, however, indicates that dopaminergic
neurons in the substantia nigra display increased oxidation
levels also in normal, physiological conditions; differently than
pathological oxidation, the importance of this phenomenon is
underappreciated. The nigrostriatal dopaminergic system is
involved in behavioral strategies that have been under strong
evolutionary pressure. It is therefore improbable that
physiological oxidation in dopamine neurons is accidental.
Here, we review recent literature to argue that moderate
oxidation improves redox signaling – which in dopamine
neurons is intertwined with electrophysiological activity and is
important to regulate dopamine release – and also has a
protective role. We also reason that physiological oxidation
provides an example of antagonistic pleiotropy therefore
offering an advantage during reproductive stages of life while
becoming detrimental during aging. Collectively, we believe
that these observations provide a new perspective in the
biology of dopaminergic neurons and in PD.
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Parkinson’s disease (PD) is a neurodegenerative disorder
primarily affecting dopaminergic neurons in the nigrostriatalwww.sciencedirect.com pathways of the brain. Dopaminergic loss displays anatomi-
cal specificity and is more pronounced the lateral ventral tier
of the substantia nigra pars compacta (SNpc); dopamine
neurons in the ventral tegmental area (VTA) are relatively
spared [1]. PD etiopathogenesis is complex and stems from
detrimental synergies between genetic and environmental
factors, ultimately perturbing crucial processes in the cell.
PD is largely sporadic and monogenic forms represent only
5% of total cases [2]. Studies on monogenic PD, however,
have been instrumental to unravel pathogenic mechanisms.
Atpresent,PDhasbeenassociatedwith19loci,which inturn
havebeenunambiguouslyassignedto11genes(PDgenetics
has been reviewed in several excellent articles, e.g. Ref. [3]).
Thelatterare involved indifferentbiologicalprocesses, from
protein quality control to endocytic trafficking, to redox
homeostasis, therefore reinforcing the complexity of PD
etiopathogenesis.
Oxidation and PD
Despite the recognized intricacy of PD pathobiology,
however, oxidative stress received continued attention
since the seminal work of Langston et al. [4] describing
parkinsonism in young subjects intoxicated with MPTP.
Follow-up studies, in fact, demonstrated a direct inhibi-
tory effect of MPTP on mitochondrial respiratory com-
plex I with consequent increase in reactive oxygen spe-
cies (ROS) production [5]. After its detection in patients’
specimens, oxidative stress rapidly became regarded as a
highly plausible PD mechanism [6,7]. Importantly, altera-
tions in redox homeostasis have been detected in animal
models harboring mutations in PD-associated genes [8].
Additionally, PD modeling largely relies on induction of
oxidative stress and virtually all the accepted toxicological
models are based on chemicals that ultimately function as
pro-oxidants [9]. Oxidative stress, therefore, remains a
recurrent factor of both genetic and idiopathic PD, and a
point of convergence in the pathogenic cascade. More
recently, the concept of oxidative stress in PD evolved in
light of the crucial role of oxidation in normal biological
function, where physiological alterations of the intracel-
lular oxido-reductive (redox) state modify sensitive resi-
dues in proteins to modulate their activity [10]. The
process largely operates via reversible oxidation of thiols
in cysteine residues and is referred to as thiol redox
signaling.
The topic of oxidative stress and redox signaling in
neurodegeneration and in PD has been comprehensively
reviewed in several and even very recent articles, and it is
not our intention to revisit the information provided inCurrent Opinion in Physiology 2019, 9:73–78
74 Redox regulationthese excellent publications [11–13]. We would rather
like to emphasize few underappreciated aspects concern-
ing the redox metabolism of dopaminergic neurons in
normal conditions and the potential physiological
consequences.
Oxidation and dopaminergic neurons
Dopaminergic neurons have distinctive redox properties.
Here, a first supportive evidence comes from studies in
toxicological models of PD, which clearly show that
selective dopaminergic degeneration can be elicited
not only by molecules specifically targeting dopaminergic
neurons (e.g. MPTP), but also by chemicals acting sys-
temically, for example rotenone and paraquat [14,15].
Another important evidence comes from studies that
measure the intracellular redox state of dopaminergic
neurons. Guzman et al. [16] used a redox-sensitive green
fluorescent protein (roGFP) [17] to demonstrate that in
brain slices, in normal conditions (i.e. in the absence of
pathology), dopamine neurons in the SNpc are more
oxidized than those in the VTA. roGFP equilibrates –
very slowly [18] – with the GSH/GSSG redox couple.
Here, it should be emphasized that redox homeostasis
relies also on additional couples, for instance thiols in
thioredoxins [19,20], and that these systems are not at
equilibrium, that is oxidation in one couple does not
necessarily implies oxidation in the other [21]. Informa-
tion inferred with roGFP is therefore necessarily limited
to a specific aspect of the intracellular redox state. In a
parallel approach, we took advantage of thiol-specific
probes conjugated to fluorescent dyes to achieve differ-
ential labeling of oxidized and reduced cysteines to infer
the global thiol/disulfide redox state in dopaminergic
neurons at single cell level [22,23]. Our experiments
confirmed higher oxidation in dopaminergic neurons of
the SNpc when compared to those of the VTA or to other
neurochemical subtypes of neurons in the cortex [23].
While the method we developed and used in these
measures cannot discriminate between specific redox
couples, it provides an overview of the general
redox state of the cell. In combination with the results
of Guzman et al., our study provides converging evidence
that the thiol/disulfide redox state is oxidized in dopa-
minergic neurons, in normal conditions, without ongoing
pathology.
Which are the causes underlying increased
oxidation?
Increased oxidation in the thiol/disulfide redox couple in
dopaminergic neurons is consistent with other elements.
Some evidence indicates that expression of ROS scav-
enging enzymes catalase, Cu/Zn SOD dismutase, and
glutathione peroxidase is lower in the SNpc than in
the VTA [24,25]. To refine those observations, we took
advantage of publicly available datasets from transcrip-
tomic studies performed at single-cell level [26] to
explore the expression levels of key genes in redoxCurrent Opinion in Physiology 2019, 9:73–78 metabolism in embryos and seven days old mice. We
found that expression of redox genes significantly
decreases after birth; however, we could not detect major
visible differences between dopaminergic neurons in the
SNpc and those in the VTA (Figure1). These data do not
exclude differences, which could be detectable at protein
level, but certainly suggest that there are no ostensible
transcriptional differences in SNpc dopaminergic
neurons.
The SNpc also contains high iron levels [27], which can
induce oxidation, especially in combination with H2O2
via Fenton chemistry [6]. Because H2O2 is abundantly
produced by the enzyme monoamine oxidase during
dopamine degradation, dopaminergic neurons in the
SNpc appear to be particular inclined to oxidation.
Finally, high production of ROS has been also attrib-
uted to the distinctive electrophysiological properties
of SNpc dopaminergic neurons. Some studies indicate
that pacemaking activity (described below in the text)
depends on calcium influx through voltage-dependent
Cav1.3 channels, and that calcium is buffered by mito-
chondria, which in turn produce superoxide during the
process [18,28]. For sake of completeness, it should
also mentioned that other experiments attribute a less
prominent role to calcium in dopamine neurons pace-
making activity especially in aging, which remains PD
major risk factor [29,30]. Nonetheless, data generated
independently, using different approaches, are consis-
tent with the observation that the thiol/disulfide redox
state in SNpc dopamine neurons is more oxidized than
in other neuronal subtypes in normal conditions.
Oxidation and evolution
Unlike oxidative stress in PD, the concept that SNpc
dopamine neurons display increased oxidation also in
normal conditions has not received commensurate
attention. Yet, this is an important issue because it
is highly conceivable that a basal oxidized redox state
underlies the particular vulnerability of SNpc dopa-
mine neurons to pro-oxidants,  therefore predisposing
to PD pathogenesis. Here, it should also be empha-
sized that available evidence indicates that SNpc
dopamine neurons do not put in place mechanisms
to mitigate oxidation in normal conditions, as inferred
from level previous literature and from transcriptomic
analysis at single-cell level [26] of major redox genes
(Figure 1). It is very unlikely that this distinctive
biochemical characteristic is accidental. The dopa-
mine system is in fact essential to adapt behavioral
strategies to environmental stimuli: given an external
input, it has a role in selecting the most appropriate
motor program and in learning new advantageous
schemes. Simply put, the dopamine system is crucial
to learn how to discriminate between positive and
negative stimuli, and what actions should be put in
place to take advantage of beneficial situations whilewww.sciencedirect.com
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Two-way cluster analysis of single cell next generation RNA sequencing data (GSE108020) [26] from embryonic (E15) and post-natal (p7) mice
illustrating expression levels of major genes involved in redox metabolism. While expression of redox genes is clearly higher in embryonic neurons,
in post-natal specimens no obvious differences can be appreciated between different areas, including between the SN (MB.4) and the VTA (MB.1).
Abbreviations for E15: FB.1: forebrain neuroblast; FB.2: post-mitotic forebrain tyrosine hydroxylase-positive (Th+) neurons; MB.1: midbrain
neuroblast; MB.2: post-mitotic midbrain DA neuron. Abbreviations for P7: FB.1: arcuate nucleus neuroendocrine Th+ neurons; FB.2 mixture of
arcuate nucleus Th+ subtypes; MB.1: ventral tegmental area; MB.2: postnatal neuroblast; MB.3: periaqueductal gray area; MB.4: substantia nigra;
OB.1: least mature Th+ neurons; OB.2: progressively maturing Th+ neurons; OB.3: most mature Th+ neurons. Genes abbreviations: Prdx1-6:
peroxiredoxin 1–6; Nxn: nucleoredoxin; Gclc: g-glutamylcysteine synthetase, glutamate cysteine ligase; Txnrd1-2: thioredoxin reductase 1–2;
Glrx1-5: glutaredoxin 1–5; Txn1-2: thioredoxin1-2.avoiding dangerous ones [31,32]. It is therefore obvi-
ous that the dopamine system has been under strong
evolutionary pressure. The question is therefore why
dopamine neurons evolved with a physiologically oxi-
dized intracellular environment despite this feature
poses risks for neurodegenerative diseases. Obviously,
it is highly plausible that this question has multiple
answers. One possibility, however, is that increased
oxidation is functional for intense redox signaling,
which is required in dopamine neurons in the SNpc
to fulfil their physiological properties.www.sciencedirect.com Physiology of DA neurons and redox signaling
Activity of dopaminergic neurons and subsequent regu-
lation of dopamine release is a complex topic that has
been reviewed in several excellent articles [31,32,33].
For the purposes of this review, it is sufficient to provide a
succinct overview of the process. Dopamine neurons
display two dominant activity patterns (i.e. firing pat-
terns), the tonic and the phasic modes. The tonic mode
is characterized by spontaneous, regular activity that is
associated with a steady level of dopamine, which is
necessary to maintain normal function in the relatedCurrent Opinion in Physiology 2019, 9:73–78
76 Redox regulationcircuits [34,35]. In contrast, the phasic mode is character-
ized by sharp activity changes, that is bursts, that cause
large changes in dopamine levels and may be initiated by
different types of reward related stimuli [34–36]. The
phasic mode is therefore highly relevant from the stand-
point of the behavioral response. Among the various
factors contributing to bursting control, at least by two
types of ionic channels have a relevant role in the process:
the ATP-sensitive potassium (K-ATP) channels and
NMDA receptors, which can also act in concert to poten-
tiate tonic firing [37,38].
K-ATP channels are octameric complexes composed of
four potassium inwardly rectifying channels (Kir6.X, typ-
ically Kir6.2 in neurons [39]) forming the pore, and four
sulfonylurea receptor units (SUR1 or SUR2) that consti-
tute the regulatory units [40]. Opening of K-ATP chan-
nels can be elicited by multiple factors associated with the
metabolic status of the cell (reviewed in Ref. [41]) and
causes membrane hyperpolarization, which in turn cul-
minates in reduced electrical activity. This mechanism
can serve as a neuroprotective strategy in conditions of
metabolic distress such as hyperactivity during seizure
[42,43] or excitotoxicity [44]. In SNc dopaminergic neu-
rons, redox activation – for instance following H2O2
mediated opening of K-ATP – emerged as an important
mechanism to regulate dopamine release [45,46]. The
mechanism operates via modification of redox sensitive
cysteine residues [47], is mediated by the regulatory
subunit SUR1 [45], and one study identified at least
two-specific residues in the regulatory subunit SUR1 via
site-directed mutagenesis [48]. Because expression of
SUR1 has been associated with metabolic sensitivity
and predisposition to dopaminergic degeneration, and
in light of the distinctive redox properties of SNpc
dopamine neurons, these findings are highly relevant
for both dopamine neurons physiology and PD [49,50].
Also, NMDA receptors, which mediate calcium influx in
the cell, can contribute to SNpc dopamine neurons’
bursts in phasic mode. NMDA receptor activation alone,
however, is not sufficient to switch neurons to the phasic
mode and require other hyperpolarizing currents, for
instance upon extrusion of sodium ions [51], or by K-
ATP channel activation, which potentiate phasic burst
firing [38]. Also NMDA receptors are redox regulated
and oxidation of sensitive cysteine residues inactivates
the channel [52,53]. Thus, while both NMDA receptors
and K-ATP channels sense the surrounding redox state,
oxidation elicits opposite consequences. The physiologi-
cal consequences of the different redox behavior of these
channels will have to be addressed in future studies;
however, the combination of redox mediated closure of
NMDA receptor and K-ATP channel opening may pre-
vent excitotoxicity while contrasting overexcitability, and
may reflect a concerted strategy to protect against oxida-
tive stress.Current Opinion in Physiology 2019, 9:73–78 Thiol/disulfide redox state and H2O2 signaling
Collectively, the discussed findings highlight the rele-
vance of H2O2 signaling for the physiology of SNpc
dopaminergic neurons and its importance in governing
behavioral aspects that have been highly exposed to
evolutionary pressure (also discussed in Ref. [28]).
The question is whether increased intracellular oxidation
in the thiol/disulfide network could be beneficial for this
process.
The mechanics governing H2O2 redox signaling are com-
plex and some of their aspects of are only rudimentarily
understood (reviewed in Ref. [54]). It is for instance
unclear how specificity is ensured in H2O2 signaling
and in particular which chemical, biological, and struc-
tural criteria drive targeted modification of a certain
cysteine residue. Another major issue stems from the
very modest reactivity of protein thiols toward H2O2
(k  101–102M1 s1) [55]. How can cysteine modifica-
tion occur in a time frame compatible with neuronal
physiological needs? It could be argued that the reaction
efficiency would be highly improved in proximity of
H2O2 sources, where local concentrations are particularly
high. At least in the case of K-ATP channels, however,
some evidence indicates that H2O2 signaling originates
from mitochondria rather than plasma membrane proteins
such as NADPH oxidase [46], and proximity between
H2O2 and its target is therefore questionable. Further
complication arises from the far higher rate constants
(k  105–108M1 s1) of H2O2 scavenging enzymes –
for instance peroxiredoxins (Prxs) – which are generally
abundantly expressed. Very recent evidence suggests that
Prxs might mediate H2O2 signaling to overcome low rates
of reaction and lack of specificity [56]; nonetheless, it
cannot be excluded a priori that Prxs may quench, or even
neutralize, H2O2 function as second messenger.
We hypothesize that constitutively higher oxidation in
the thiol/disulfide couple could favor H2O2 at least in
three ways. (1) Oxidation in a subpopulation of intracel-
lular thiols would increase the relative concentration of
H2O2, therefore favoring its action as a second messenger.
This hypothesis implies that factors such as the in vivo
redox potential of protein thiols will determine which
residues will be oxidized in basal conditions, and also
implies that proteins such as K-ATP channels will remain
in a reduced state. Redox proteomic studies will be
necessary to address this possibility. Additionally, experi-
ments in which measures of redox signaling effectiveness
will be paralleled by rigorous measures of intracellular
redox state a single cell level will be necessary to conclu-
sively assess the effect of dopaminergic neurons basal
oxidation on H2O2 as second messenger. (2) Increased
cysteine oxidation could also block the active site of Prxs,
which are particularly sensitive to H2O2 mediated thiol
oxidation, as also indicated by redox proteomics studies
[57,58]. (3) Multiple lines of evidence indicate thatwww.sciencedirect.com
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neurons because of higher production and/or lower scav-
enging. In this chemical context, an increase in reversible
cysteine oxidation may represent a protective strategy
against irreversible and more dangerous forms of oxida-
tion caused by high ROS levels. Accordingly, we have
recently shown that moderate, reversible oxidation pro-
tects the dopaminergic system in multiple animal models
of PD [59].
Are these observations important for PD?
Thiol/disulfide oxidation in normal conditions in SNpc
dopamine neurons could be an example of antagonistic
pleiotropy, that is a trait that is favorable during repro-
ductive stages of life – for instance to improve novelty-
induced exploration – and is therefore under evolutionary
pressure, but becomes detrimental during aging [60,61].
Increased oxidation may provide the substrate for
genetic and environmental factors to trigger dopaminer-
gic degeneration. Moreover, some evidence indicates that
moderate oxidation might be protective in PD and thus
preservation of tolerable level of reversible cysteine oxi-
dation may constitute an experimental therapy worth
exploring.
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